Skip to main content

Articles

Page 7 of 7

  1. Despite major advances in drug development, effective cardiovascular therapies and suitable cardiovascular biomarkers remain limited. The aim of this study was to leverage mass spectrometry (MS) based peptide ...

    Authors: Bing Hui Wang, Simone Reisman, Mark Bailey, Andrew Kompa, Mustafa Ayhan, Henry Krum and Gregory Rice
    Citation: Clinical and Translational Medicine 2012 1:11
  2. For many common global diseases, such as cancer, diabetes, neurodegenerative and cardiovascular diseases there is an unmet need for diagnosing early indications of disease that could enable medical interventio...

    Authors: György Marko-Varga, Ákos Végvári, Melinda Rezeli, Kaiu Prikk, Peeter Ross, Magnus Dahlbäck, Goutham Edula, Ruth Sepper and Thomas E Fehniger
    Citation: Clinical and Translational Medicine 2012 1:8
  3. Severe sepsis is a major concern of public health in industrialized countries. It is estimated that in the United States 200,000-400,000 cases occur annually and resulting in an extensive burden for the health...

    Authors: Markus Bosmann and Peter A Ward
    Citation: Clinical and Translational Medicine 2012 1:4
  4. It has been more than a decade that the term "Translational" (medicine, Research, Science) has trickled through the minds of academics, clinicians, business persons, regulators, policy makers, patients and the...

    Authors: Xiangdong Wang and Francesco M Marincola
    Citation: Clinical and Translational Medicine 2012 1:3
  5. "It's not what we do, it's the way that we do it". Never has this maxim been truer in proteomics than now. Mass Spectrometry-based proteomics/phosphoproteomics tools are critical to understand the structure an...

    Authors: Elena López, Sarbelio Rodríguez Muñoz, Juan López Pascual and Luis Madero
    Citation: Clinical and Translational Medicine 2012 1:2